[go: up one dir, main page]

AR002728A1 - Un procedimiento para inhibir la fotodescomposicion de 2-oxindol-1- carboxamidas 3-sustituidas y una composicion farmaceutica que comprende dichaoxindol-carboxamida asi inhibida. - Google Patents

Un procedimiento para inhibir la fotodescomposicion de 2-oxindol-1- carboxamidas 3-sustituidas y una composicion farmaceutica que comprende dichaoxindol-carboxamida asi inhibida.

Info

Publication number
AR002728A1
AR002728A1 ARP960101956A AR10195696A AR002728A1 AR 002728 A1 AR002728 A1 AR 002728A1 AR P960101956 A ARP960101956 A AR P960101956A AR 10195696 A AR10195696 A AR 10195696A AR 002728 A1 AR002728 A1 AR 002728A1
Authority
AR
Argentina
Prior art keywords
carboxamide
substituted
carboxamides
inhibited
inhibiting
Prior art date
Application number
ARP960101956A
Other languages
English (en)
Spanish (es)
Inventor
Willard C Newlin Jr
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR002728A1 publication Critical patent/AR002728A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
ARP960101956A 1995-04-24 1996-03-28 Un procedimiento para inhibir la fotodescomposicion de 2-oxindol-1- carboxamidas 3-sustituidas y una composicion farmaceutica que comprende dichaoxindol-carboxamida asi inhibida. AR002728A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
AR002728A1 true AR002728A1 (es) 1998-04-29

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101956A AR002728A1 (es) 1995-04-24 1996-03-28 Un procedimiento para inhibir la fotodescomposicion de 2-oxindol-1- carboxamidas 3-sustituidas y una composicion farmaceutica que comprende dichaoxindol-carboxamida asi inhibida.

Country Status (30)

Country Link
EP (1) EP0827399A1 (pt)
JP (1) JPH10506635A (pt)
KR (1) KR100189585B1 (pt)
CN (1) CN1053667C (pt)
AP (1) AP607A (pt)
AR (1) AR002728A1 (pt)
AU (1) AU692378B2 (pt)
BG (1) BG100531A (pt)
BR (1) BR9602024A (pt)
CO (1) CO4700418A1 (pt)
FI (1) FI973988A0 (pt)
HR (1) HRP960194A2 (pt)
HU (1) HU216544B (pt)
IL (1) IL117969A0 (pt)
IS (1) IS4339A (pt)
MA (1) MA23848A1 (pt)
NO (1) NO961622L (pt)
NZ (1) NZ286432A (pt)
OA (1) OA10286A (pt)
PE (1) PE34397A1 (pt)
RO (1) RO113305B1 (pt)
RU (1) RU2109510C1 (pt)
SG (1) SG64924A1 (pt)
SI (1) SI9600133A (pt)
SK (1) SK51296A3 (pt)
TR (1) TR199600300A2 (pt)
UA (1) UA42739C2 (pt)
WO (1) WO1996033701A1 (pt)
YU (1) YU25096A (pt)
ZA (1) ZA963210B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2758128C1 (ru) 2017-12-29 2021-10-26 Крафт Фудс Груп Брэндс Ллк Улучшенная устойчивость к окислению эмульсий типа "масло в воде" при помощи натуральных стабилизаторов

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
HUP9601057A2 (en) 1997-04-28
HUP9601057A3 (en) 1997-05-28
YU25096A (sh) 1998-08-14
SK51296A3 (en) 1997-04-09
PE34397A1 (es) 1997-09-29
JPH10506635A (ja) 1998-06-30
FI973988A7 (fi) 1997-10-17
TR199600300A2 (tr) 1996-11-21
MA23848A1 (fr) 1996-12-31
BR9602024A (pt) 1998-10-06
SI9600133A (en) 1996-10-31
AU5085196A (en) 1996-11-07
SG64924A1 (en) 1999-05-25
CN1053667C (zh) 2000-06-21
HRP960194A2 (en) 1998-02-28
UA42739C2 (uk) 2001-11-15
WO1996033701A1 (en) 1996-10-31
FI973988L (fi) 1997-10-17
RU2109510C1 (ru) 1998-04-27
IL117969A0 (en) 1996-08-04
CN1139110A (zh) 1997-01-01
RO113305B1 (ro) 1998-06-30
HU9601057D0 (en) 1996-06-28
FI973988A0 (fi) 1997-10-17
IS4339A (is) 1996-10-25
BG100531A (bg) 1997-06-30
KR960037656A (ko) 1996-11-19
EP0827399A1 (en) 1998-03-11
KR100189585B1 (ko) 1999-06-01
NO961622D0 (no) 1996-04-23
OA10286A (en) 1997-09-19
CO4700418A1 (es) 1998-12-29
HU216544B (hu) 1999-07-28
AP607A (en) 1997-08-27
AP9600787A0 (en) 1996-04-30
NO961622L (no) 1996-10-25
NZ286432A (en) 1998-05-27
AU692378B2 (en) 1998-06-04
ZA963210B (en) 1997-10-23

Similar Documents

Publication Publication Date Title
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
TW200509905A (en) Pharmaceutical compositions of atorvastatin
MY128654A (en) Liquid pharmaceutical composition containing an erythropoietin derivative
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
TW200510349A (en) Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
PT1041987E (pt) Forma farmaceutica de dosagem oral, compreendendo uma combinacao de um agonista de opioide e naltrexona
AR012717A1 (es) Trihidrato de la sal de magnesio de s-omeprazol, proceso para su preparacion, composicion farmaceutica, y uso de dicho trihidrato para la fabricacion de medicamentos.
PL373903A1 (en) A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
MA26516A1 (fr) Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant.
BR0213355A (pt) composições farmacêuticas
BRPI0412557A (pt) forma de dosagem farmacêutica de eventos cardiovasculares
LT2001119A (en) Pharmaceutical formulations comprising intranasal morphine and use thereof
SI1546127T1 (sl) Novi pirimidinamidni derivati in njihova uporaba
ATE230993T1 (de) Pharmazeutische zusammensetzung zur behandlung von alkoholabhängigkeit, die opioid antagonisten mit nmda-rezeptorkomplex-modulatoren enthält
UA85359C2 (ru) Таблетка, содержащая гранулированный материал с kmd-3213
DE122006000057I2 (de) Proteinhaltige arzneimittel
TW200503689A (en) Pharmaceutical compositions of atorvastatin
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
KR970061249A (ko) 골다공증을 치료 또는 방지하기 위한 조성물
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
ATE400563T1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
AR002728A1 (es) Un procedimiento para inhibir la fotodescomposicion de 2-oxindol-1- carboxamidas 3-sustituidas y una composicion farmaceutica que comprende dichaoxindol-carboxamida asi inhibida.